For the first time ever in the world, researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have produced a blood vessel from stem cells and then used it in an operation on a 10-year-old girl at the Sahlgrenska University Hospital.

Researchers in Bochum have produced an antibody that allows them to distinguish the numerous types of stem cells in the nervous system better than before.

Researchers at Columbia Engineering have established a new method to patch a damaged heart using a tissue-engineering platform that enables heart tissue to repair itself.

Starting with this article, InvitroJobs will present scientists and their innovative research in a regular feature called “Working Group – a Portrait”.
We will focus on newly developed methods, their evaluation and their potential for reducing and where possible replacing animal experimentation according to the 3R principle of Russel & Burch (reduce, refine, replace). We start with two research groups from the Clinical Research Laboratory of the Paediatric Cardiac Surgery Department of Tübingen University Hospital, “Haemocompatibility” and “Pyrogen assay”. The introduction is followed by an interview with Dr. med. Stefan Fennrich.